Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: FranciaországFázis nélkül

Diagnostic Value of eVOG

A legfontosabb adatok

Ki végzi
Centre Hospitalier Universitaire de Nice
Hol
Nice (Franciaország)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
150 fő, tervezett
Kezdés
2023. ápr. 7.
Várható befejezés
2027. ápr. 1.
A vizsgálat típusa
Beavatkozással járó, 3 csoport
A vizsgált kezelések
  • eVOG
A regiszteradat frissítve
2026. június 16.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

A vizsgálat olyan felnőtteket keres, akiket az MRI-n látott fehérállományi jelek okának kivizsgálására küldtek egy harmadlagos központba, valamint kontrollként önkénteseket. A szemmozgásaikat az eVOG táblagépes alkalmazással rögzítik.

Életkor
18 évnél idősebb
Nem
Mindkét nemű jelentkező részt vehet.
A betegség stádiuma
Olyan betegek, akiket a fehérállományi hipersignalok (az MRI-n látható fehérállományi elváltozások) kivizsgálására küldtek.

A részvétel fő kizáró okai

  • A szokásos klinikai vizsgálaton talált szemmozgászavar
  • Bármilyen ideg-, szem- vagy általános betegség, amely zavarhatja a szemmozgás rögzítését
  • Ismert szemmozgászavarral élő kontrollszemélyek

A regiszter feltételei, szó szerint

Mind a 8 feltétel megnézéseKevesebb

Ki nem vehet részt

  • Presence of a neurological, ophthalmological or general pathology that may interfere with the performance of digital video oculography

Egyéb feltételek

  • Patients Inclusion Criteria:
  • Patients referred to our tertiary center for a diagnostic workup of white matter hypersignals
  • Absence of oculomotor disorders on conventional clinical examination
  • Age > 18 years; controls Inclusion criteria:
  • The controls can be recruited from the accompanying persons of the patients selected for the study, from the staff of the CHU of Nice or from the entourage of the investigating team
  • Absence of known oculomotor disorders by the control
  • Age > 18 years

Helyszínek itt: Franciaország

  • Nice University HospitalNice, FranciaországContact: Cassandre LANDES-CHATEAURésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

Eye movement is a complex neurological function controlled by many structures located in the central nervous system. The eyeball is mobile within the orbit and its movements are carried out using 6 muscles innervated by 3 oculomotor nerves allowing to perform reflex or voluntary eye movements in all elementary directions.

A teljes eredeti leírásKevesebb

So-called internuclear structures allow the two eyeballs to perform combined movements. The attack of these structures during an acute or chronic neurological disease will most often cause oculomotor paralysis in one or more directions of gaze which will be perceived by the patient as double vision.

So-called supranuclear structures make it possible to generate different types of eye movements: saccades, which are extremely rapid eye movements of very short duration, eye pursuit, which is a slow movement whose purpose is to follow a moving visual target and finally, certain neural circuits are intended to stabilize the gaze.

Many neurological diseases can be accompanied by oculomotor abnormalities affecting saccades or ocular pursuit. These include neurodegenerative diseases characterized by diffuse neurological damage.

Involvement of gaze stabilization structures is also frequently found in certain neurological diseases affecting the posterior fossa.

The clinical examination of oculomotricity focuses mainly on the analysis of ocular mobility in the different directions of space by asking the subject to fix an object (for example a pen) or the index of the examiner in moving in different directions in space. During a classic clinical examination, it is then possible to detect anomalies such as oculomotor paralysis or nystagmus, it is however very difficult to assess the speed or the precision of the saccades, as well as the quality of the pursuit ocular.

As a result, the development of techniques to accurately record eye movements has emerged as a need in order to help in the diagnosis of certain visual disorders and certain neurodegenerative diseases.

Video oculography (VOG) is a technique for precisely recording and analyzing the movements of the eyeballs.

The use of VOG in neurology has long been dominated by helping to diagnose certain neurodegenerative diseases and in particular certain atypical Parkinson's syndromes. The value of VOG has also been demonstrated in certain pathologies characterized by atrophy of the brainstem or cerebellum, of hereditary or acquired origin. Some studies have also assessed its contribution to the diagnosis and management of certain dementias and certain psychiatric diseases such as schizophrenia. More recently, the interest of VOG has also emerged in the management of patients with a demyelinating disease of the multiple sclerosis spectrum.

The VOG has a number of limitations to its large-scale use, first of all, it is an examination requiring specific, relatively expensive equipment. On the other hand, the examination requires know-how, both for the passing of the tests but also for the processing and analysis of the data.

The eVOG (mobile VideoOculoGraphy) application has been developed to record oculomotor movements during different paradigms: horizontal saccades, vertical saccades, antisaccades, horizontal pursuit, vertical pursuit thanks to a tablet fixed on a support allowing keep in a stable and fixed position.

The eVOG app was compared to a conventional VOG platform in a first study. The objective was to compare the measurements obtained by the eVOG application to the measurements collected by the standard method in a sample of patients with multiple sclerosis. This study showed that the detection of different anomalies by eVOG is correlated with classic VOG.

In view of these encouraging preliminary results, a prospective study could be set up with the objective of evaluating the value of digital VOG in the diagnostic process in patients referred to a tertiary center for white matter signal abnormalities on MRI.

the hypothesis is that subclinical oculomotor disorders will be found more frequently in the group of patients with MS spectrum disease due to the presence in this pathology of diffuse inflammatory and degenerative damage to brain tissue, unlike the others inflammatory or non-inflammatory pathologies.

A vizsgálat 3 csoportja

  • suggestive demyelinating diseaseEgyéb csoport

    White matter lesions suggestive demyelinating diseases

    Kezelés: eVOG

  • no suggestive demyelinating diseasesEgyéb csoport

    White matter lesions not suggestive demyelinating diseases

    Kezelés: eVOG

  • ControlsEgyéb csoport

    patients controls

    Kezelés: eVOG

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Diagnostic Value of Digital Video Oculography in Patients With White Matter Lesions
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 12.
A regiszteradat frissítve
2026. június 16.